Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 12.40
+0.40 (3.33%)
At close: Feb 26, 2026
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €93.3 million as of February 26, 2026. Its market cap has increased by 390.99% in one year.
Market Cap
93.30M
Enterprise Value
91.43M
Revenue
8.09M
Ranking
n/a
PE Ratio
47.79
Stock Price
€12.40
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 93.30M, an increase of 507.08%. That is a compound annual growth rate of 57.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 90.29M | 40.35% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.78B |
| Laboratorios Farmaceuticos Rovi | 4.02B |
| Almirall | 2.88B |
| Faes Farma | 1.61B |
| Oryzon Genomics | 247.60M |
| Atrys Health | 235.21M |
| Prim, S.A. | 221.21M |
| Laboratorio Reig Jofre | 211.62M |